Reflection on COVID-19 vaccine development process and ongoing animal studies
-
Expectation of COVID-19 dominance for the next 15-20 years • 0:24
-
Importance of significant research to corroborate findings • 1:45
-
Comparison of normal vaccine development timeline vs. COVID-19 vaccine timeline • 3:05
-
Concerns and justification for speeding up vaccine development • 3:56
-
Acceleration of vaccine approval process during the pandemic • 4:04
Lack of ongoing animal studies for COVID vaccines raises concerns about safety and efficacy
-
Limited pre-clinical studies involving animals were conducted for COVID vaccines • 4:49
-
No gene toxicity or carcinogenicity studies were performed due to vaccine components • 5:53
-
No separate studies on local tolerance, prenatal/postnatal development, or reproductive toxicity were conducted • 6:47
-
Concerns raised about the lack of ongoing animal studies and approval process for vaccine use in pregnant women • 7:10
-
World Health International clinical trials registry shows no ongoing animal studies for COVID vaccines • 8:30
Lack of ongoing research on COVID vaccine effects raises concerns about potential long-term consequences
-
Limited ongoing research on the effects of COVID vaccines on patients who have died • 9:32
-
Absence of sufficient autopsies to understand disease patterns and potential risks • 10:40
-
Critical questions raised about responsibility and reasons for the lack of ongoing animal studies • 11:16
-
Concerns about triggering autoimmune responses due to lack of comprehensive research • 11:58
-
Potential challenges for the population in the next 15-20 years without adequate research • 12:08